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Presence of N regions in the clonotypic DJ rearrangements of the
immunoglobulin heavy-chain genes indicates an exquisitely short latency in
t(4;11)-positive infant acute lymphoblastic leukemia
Karin Fasching, Simon Panzer, OskarA. Haas, Arndt Borkhardt, Rolf Marschalek, Frank Griesinger, and E. Renate Panzer-Gru ¨mayer
Childhood acute lymphoblastic leukemia
(ALL) is frequently initiated in utero at a
time of developmentally regulated inser-
tion of N regions into the DJH rearrange-
ments of immunoglobulin heavy-chain
(IgH) genes. Here it is shown that N re-
gions are present in the clonotypic DJH
rearrangements in 11 of 12 infant ALLs
with t(4;11). These data are compared
with the 122 previously published DJH
sequences and were found to have a
pattern similar to that of ALL in children
older than 3 years at diagnosis but were
unlike that in children younger than 3
years who predominantly lack N regions.
These ﬁndings, therefore, indicate that
t(4;11)-positive infantALLis initiated later
in fetal development than most B-cell
precursorALLfromchildrenyoungerthan
3 years and that they have a shorter
latency period already in utero. (Blood.
2001;98:2272-2274)
© 2001 by TheAmerican Society of Hematology
Introduction
Childhood acute lymphoblastic leukemia (ALL) is a heterogeneous
group of leukemias with a predominance of the B-cell precursor
(BCP) phenotype.Aminority of these leukemias is associated with
a translocation involving the mixed-lineage leukemia (MLL) gene
on chromosome 11q23 that is fused, in 50% of patients, to the AF4
gene on chromosome 4q21.1 The chromosomal translocation
t(4;11)(q21;q23) occurs mostly in infantALL and confers a dismal
prognosis in this age group, whereas in older children and adults
the prognosis does not differ from t(4;11)-negative cases.2,3 Differ-
ences in the chromosomal breakpoints of the MLL gene between
infants and children or adults with t(4;11) ALL suggest different
mechanisms for the development of these instances of ALL4 and,
thus, their different biologic functions.
Greaves5 proposed a 2-step model for the development of ALL
with an initiating event in utero, followed by a second mutation
leading to overt leukemia. Indeed, leukemia-speciﬁc chromosomal
translocations and clonotypic antigen-receptor gene rearrange-
ments at birth recently conﬁrmed the initiation of childhoodALLin
utero.6-9 Thus, depending on the time of clinical manifestation, the
latency period varies among the different types of leukemia. In
contrast to leukemias with long latency periods for which a
chromosomal translocation and additional postnatal mutations are
required,9 the extremely short latency periods in infant ALL (with
MLL rearrangements) suggest only limited further mutagenic
requirements.1 It seems likely that not only postnatal but also
prenatal development of the disease is rapid.
Assuming that the gene fusion resulting from t(4;11) in infant
ALL is indeed an initiating event, its origin must be restricted to a
period between the beginning of B lymphopoiesis in the fetal
liver—ie, the 6th gestational week10—and possibly a few months
before the diagnosis of leukemia.11 This translocation is assumed to
occur in a cell that has already started to rearrange its IgH genes.
The time period of these rearrangement processes during fetal
development can be determined by the presence or absence of N
regions between the DJH joinings. The addition of N nucleotides
requires terminal deoxynucleotidyl transferase (TdT) that is not
initially present in fetal lymphopoiesis but that has been observed
by the end of the ﬁrst trimester of gestation.12-14
We therefore used the leukemia clone-speciﬁc junctional re-
gions of DJH rearrangements to determine the time point of a ﬁrst
mutation in utero in t(4;11) ALL in infancy. We show the presence
of N regions between the DJH joinings in 11 of 12 infantALLs with
t(4;11) indicating their initiation at a later time during fetal
development than most other leukemias that become apparent
during the ﬁrst 3 years of life.
Study design
The occurrence of t(4;11)ALLwas analyzed in 13 infants. Inclusion criteria
were patient age younger than 1 year at diagnosis and the presence of at
least one clonotypic IgH rearrangement (Figure 1). All leukemias had a pro
B phenotype with frequent coexpression of myeloid markers. The local
institutional ethical committee approved the study, and informed consent
was obtained from the parents.
DNA was extracted from cells by standard procedures.15 Ampliﬁcation
of the ret-oncogen conﬁrmed the integrity of DNA in all samples. Clonal
IgH rearrangements were determined by VH-family–speciﬁc and JH consen-
sus primers for the ampliﬁcation of V(D)JH rearrangements and of primer
sets for the ampliﬁcation of all incomplete DJH rearrangements, as
described previously.16,17 Ampliﬁed products were sequenced directly, and
involved gene segments were identiﬁed by BLAST sequence similarity
From the Children’s Cancer Research Institute, StAnna Kinderspital, and Clinic
for Blood Group Serology, University of Vienna, Austria; the Department of
Pediatric Hematology/Oncology, Justus Liebig Universita ¨t, Giessen, Institute of
Pharmaceutical Biology, University of Frankfurt; and the Department of
Hematology/Oncology, University of Go ¨ttingen, Germany
Submitted March 2, 2001; accepted May 29, 2001.
Supported in part by the O ¨ sterreichische Kinderkrebshilfe and by a grant from
the Deutsche Krebshilfe (Bo 10-124.3).
Reprints: E. Renate Panzer-Gru ¨mayer, Children’s Cancer Research Institute,
St Anna Kinderspital, Kinderspitalgasse 6, A-1090 Vienna, Austria; e-mail:
panzer@ccri.univie.ac.at.
The publication costs of this article were defrayed in part by page charge
payment. Therefore, and solely to indicate this fact, this article is hereby
marked ‘‘advertisement’’ in accordance with 18 U.S.C. section 1734.
© 2001 by TheAmerican Society of Hematology
2272 BLOOD, 1 OCTOBER 2001z VOLUME 98, NUMBER 7
For personal use only. on November 3, 2014.  by guest    www.bloodjournal.org From searches (http://www.ncbi.nlm.nih.gov/BLAST/) and by comparison with
published sequences of all known human immunoglobulin genes (http://
www.ebi.acc.uk), allowing the assignment of nucleotides to either the V, D,
and J regions or to the Pand N regions by exclusion.
Results and discussion
We identiﬁed 16 IgH rearrangements in 13 infants with t(4;11)ALL
(Figure 1A). Ten leukemias had 1 rearrangement, and 3 leukemias
(patients 4, 8, 10) had 2 rearrangements. We considered only 1 of
the 2 rearrangements (in patients 4 and 10) because they had
identical DJH regions. We excluded the DJH rearrangement in
patient 1 because the sequence between DH and JH was homologous
to the J1 pseudogene. Thus, 13 unique rearrangements were
analyzed for the inclusion of N regions. We observed in patient 4 a
D-D fusion, but only the DH gene segment most proximal to the JH
segment was included in the analysis.As depicted in Figure 1, only
1 of the 13 unique sequences lacked N regions at the DJH junction.
The results from this study are compared with those from 122
previously published cases (Table 1). It appears that the lack of N
regions in t(4;11) infant ALL is less common than in children with
ALL who are younger than 3 years at diagnosis but that they are
about as common as in children older than 3 years.15,18,19 Figure 1
illustrates the use of DH and JH families, similar to that reported
previously.16,18,19
The data from this study indicate that most DJH regions from
infant ALL with t(4;11) contain N nucleotides that developed at a
time of TdT activity; hence, they were more mature than those
without N regions. Interestingly, other leukemias, diagnosed in
children before the age of 3, do not have N regions in their DJH
junctions15,18,19 and thus have a longer latency period than the
t(4;11) infant leukemias. There are 2 groups of BCPALL that have
N regions in their clonotypic DJH junctions, namely t(4;11) infant
ALL with a manifestation mostly in the ﬁrst year of life and other
leukemias with a clinical manifestation after the 3rd year of
life.18,19 Both rearrange their DJH segments at a similar time during
gestational development. It is obvious, however, that t(4;11) ALL
has a remarkably shorter latency than the others.
We propose a model for the relation between the time of
initiation of the leukemia, characterized by the clonotypic DJH
rearrangements, and the age of the children at clinical manifesta-
tion of BCPALL(Figure 2). IgH rearrangements that lack N regions
occur during a narrow time window—the ﬁrst weeks of B
lymphopoiesis in fetal liver that is TdT negative. Transformed cells
with such rearrangements most likely acquire additional mutations,
leading to leukemias during the ﬁrst 3 years of life. IgH rearrange-
ments with the addition of N nucleotides in the DJH junction occur
later in gestation, when TdT has already been activated. These
leukemias become clinically apparent during the ﬁrst year of life if
a t(4;11) chromosomal translocation started leukemogenesis or, in
its absence, after the 3rd year of life. Alternatively, the t(4;11)
translocation arises in a TdT-negative primitive cell without IgH
rearrangements. This target cell may represent a B-plus myeloid
lymphoid stem cell, as described by Cumano et al20 in mouse fetal
liver, which would be unique in speciﬁc stages of in utero
hematopoiesis.The N region–positive DJH rearrangement may be a
later addition during progression to leukemia. Then, unrelated
rearrangements are expected, such as in t(9;22) B lymphoid blast
crisis of chronic myeloid leukemia.16 However, in our series, no
leukemia had multiple unrelated IgH rearrangements, but 2 leuke-
mias had related rearrangements. In addition, the target cell for the
t(4;11) translocation may be a rare progenitor with TdT expression
at earlier stages of fetal lymphopoiesis than common B precursor
cells. No such cells have been identiﬁed thus far in humans.
Figure 1. Nucleotide sequence of IgH rearrangements
in t(4;11) infant ALL. Trimming of the rearranged seg-
ments is indicated by the numbers of nucleotides.
NnucleotidesbetweenDDsegmentsareshowninitalics;
shaded areas indicate sequence homology between 2
rearrangements.
Figure 2. Time frame. Development of N2 and N1 BCP leukemias in childhood.
Table 1. Occurrence of N regions between the DJH junction of children with
BCPALL and their ages at diagnosis
Age at diagnosis (y)
No. of
ALL/study
N 1
n
N 2
n Reference
Younger than 1 year 12 11 1 This study
Younger than 3 years 16 2 16 Wassermann et al18
8 5 5 Steenbergen et al19
14 4 12 Schneider et al15
Older than 3 years 46 41 10 Wassermann et al18
39 35 12 Steenbergen et al19
Leukemias are considered N1 if one DJH junction has N nucleotides inserted.
They are considered N2 if one DJH junction lacks N nucleotides. Leukemias are
included in both groups if one rearrangement contains N nucleotides and the other
does not.
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event in leukemogenesis,9,21 which can be induced by apoptotic
stimuli that lead to the generation of gene fusions in B precursor
cells, thus rescuing a cell programmed to die.22 This assumption is
supported by the ﬁndings that most IgH rearrangements inALL are
either incomplete or not potentially productive,16 underlining the
immaturity of these cells, which would not survive without a
transformation. It is further hypothesized that additional mutations
are required for the development of leukemia. However, our
ﬁndings support the hypothesis that the t(4;11) is either sufﬁcient
for leukemogenesis or provokes efﬁciently further changes that
lead eventually to leukemia in infancy.1,11
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